Arati S. Desai
Oncology
3400 Civic Center Boulevard
West Pavilion, 2nd Floor
Philadelphia, PA 19104
West Pavilion, 2nd Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
Journal: Journal of neuro-oncology
Published: March 11, 2026
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801).
Journal: AJNR. American journal of neuroradiology
Published: February 19, 2026
Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival.
Journal: Annals of clinical and translational neurology
Published: February 18, 2026
Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival.
Journal: Annals of clinical and translational neurology
Published: February 18, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.
Journal: International journal of radiation oncology, biology, physics
Published: January 15, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single-Institution Series.
Journal: International journal of radiation oncology, biology, physics
Published: January 15, 2026
Longitudinal neuropathologic and molecular characterization of a retroperitoneal ependymoma.
Journal: Journal of neuropathology and experimental neurology
Published: December 23, 2025
A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma.
Journal: Neuro-oncology advances
Published: November 23, 2025
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 29, 2025
Incidence, management, and outcomes of procarbazine-associated hypersensitivity reactions in patients receiving PCV for lower-grade gliomas.
Journal: Neuro-oncology practice
Published: October 13, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for Glioblastoma.
Journal: JCO precision oncology
Published: September 04, 2025
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.
Journal: Nature medicine
Published: August 29, 2025
Last Updated: 09/26/2026